Loading...
Loading...
Among the 10 tracked institutional investors we monitor, TEVA PHARMACEUTICAL INDS LTD is held with a combined value of $4.68B across 118,176,405 shares. The largest holder is BlackRock, Inc. with a position worth $2.51B (0.04% of their portfolio). 10 funds opened new positions in the most recent quarter.
Total Institutional Value
$4.68B
Total Shares Held
118,176,405
Institutional Holders
10
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $2.51B | 0.04% | New |
| 2 | FMR LLC | $1.02B | 0.04% | New |
| 3 | STATE STREET CORP | $764.64M | 0.02% | New |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $162.77M | 0.23% | New |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | $84.14M | 0.01% | New |
| 6 | MILLENNIUM MANAGEMENT LLC | $58.04M | 0.04% | New |
| 7 | Bridgewater Associates, LP | $38.92M | 0.17% | New |
| 8 | CITADEL ADVISORS LLC | $30.34M | 0.02% | New |
| 9 | AQR CAPITAL MANAGEMENT LLC | $5.73M | 0.00% | New |
| 10 | ARK Investment Management LLC | $2.74M | 0.02% | New |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of TEVA PHARMACEUTICAL INDS LTD with a position worth $2.51B, representing 0.04% of their portfolio. In total, 10 institutional investors hold TEVA PHARMACEUTICAL INDS LTD with a combined value of $4.68B.
In the most recent quarter, 10 funds opened a new position in TEVA PHARMACEUTICAL INDS LTD.
Institutional investors hold $4.68B worth of TEVA PHARMACEUTICAL INDS LTD stock across 10 positions. The largest institutional holder is BlackRock, Inc. with $2.51B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TEVA PHARMACEUTICAL INDS LTD, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
None this quarter.